The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study
Saved in:
Bharat, C., et al., The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Addiction, vol. 116, n. 12, 2021, p. 3139-3152.
Ref.
574333
Location:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Programas de mantenimiento, Buprenorfina, Metadona, Fármacos, Recetas médicas, Características usuario, Médicos, Retención, Factor de riesgo, Factor de protección, Australia
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Programas de mantenimiento, Buprenorfina, Metadona, Fármacos, Recetas médicas, Características usuario, Médicos, Retención, Factor de riesgo, Factor de protección, Australia
Similar Items: The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study
- OPIOID AGONIST PHARMACOTHERAPY IN NEW SOUTHWALES FROM 1985 TO 2006: PATIENT CHARACTERISTICS AND PATTERNS AND PREDICTORS OF TREATMENT RETENTION
- Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study
- Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care
- Interim opioid agonist treatment for opioid addiction: a systematic review
- A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis